Stay updated on Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A sitewide notice says NIH websites are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T16:31:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The revision identifier in the footer changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T16:18:13.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T16:22:16.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record, indicating access is blocked. This prevents viewing the study details on this page.
    Difference
    19%
    Check dated 2026-09-19T19:01:58.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The revision label changed from v3.6.5 to v3.6.6, representing a new version in the site’s revision history. It does not reflect changes to the study details or user-visible information.
    Difference
    0.1%
    Check dated 2026-08-29T19:46:04.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    New study documents with associated dates and file sizes are now linked in the Study Details page, along with updated verification timestamps from the sponsor team. This addition provides access to key consent and protocol materials and contextual metadata.
    Difference
    53%
    Check dated 2026-08-15T20:22:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.